Produkty

Prof. Hans-Ulrich Laasch, Dr. med. MRCP FRCR

The Christie NHS Foundation Trust, Manchester, UK

“The HV+ stent has shown itself to have one of the lowest migration rates across the gastro-oesophageal junction and could be demonstrated to stay in position where other stents have displaced.

As a braided, fully silicone encapsulated stent, it has a relatively high axial rigidity, which may cause issues in tight anatomical flexures, but the related high expansion force make it particularly suitable for bulky tumours.

Due to the markedly increased survival of patients after oesophageal stenting, stent durability and removability have become a much more essential property than was previously necessary. Perishing of stent coverings and failure of the stent skeleton through nitinol corrosion is now frequently observed in our institution. The HV+ is one of the most corrosion resistant stents on the market, usually allowing definitive palliation.

Where revision is required, it can be reliably removed, even after many months in situ. The steel retrieval wire is easy to identify and capture, allowing extraction of the stent, thus increasing the options for re-intervention without limitation by an existing stent.”

Natalia V. Lozhkina MD, PhD, Head of endoscopic department of the State Autonomous Healthcare

Institution of the Perm region, Clinical Hospital №4 of the Perm city

‘’The main criterion of my choice is ergonomics. HV Stent Plus meets all requirements for a convenient and predictable implantation and is also characterized by safe removal from the esophagus with minimal risk of bleeding. Stents of this design are comfortable for the patient compared to other models. They have minimal complications compared to other models in dynamic 1-2 year follow-up observation’’.

Sergei V. Zhuravlev, MD

Head of endoscopic department of the Irkutsk Regional Cancer Centre

‘’Since 2004 I have been using HV Stent Plus in my daily practice and have performed more than 1000 implantation. My choice was based on the unique antimigration design that allow to get the minimal distal migration rate in the low part of esophagus and makes me in the quality of conducted treatment’’.

Natalia V. Tchueva, MD

Head of diagnostic department of the Belgorod Regional Cancer Centre

“For me as a specialist it is very important to be sure in quality of conducted therapy. HV Stent Plus has CE mark and extensive scientific evidence-based data. All of this allow me to get perfect clinical outcomes and get positive feedback from my patients.”